LUT014, a BRAF inhibitor gel, improved acne-like rashes in patients with colorectal cancer undergoing anti-EGFR therapy, ...

Scientists at the Icahn School of Medicine at Mount Sinai have discovered a possible reason why some cases of melanoma—a ...

Scientists at the Icahn School of Medicine at Mount Sinai have discovered a possible reason why some cases of melanoma—a ...

Topical BRAF inhibitor LUT014 gel significantly reduces acneiform rash from anti-EGFR therapies in patients with colorectal ...

HonorHealth Research Institute recently treated the first patient in a 50-site international clinical trial that will test a ...

Teddi Mellencamp says looking at her cancer scars previously made her cry but now brings her peace: 'Peace in knowing my ...

Real Housewives of Beverly Hills' alum Teddi Mellencamp just gave an unflinching look at the cancer scars on her head and ...

According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...

Researchers from the UCLA Health Jonsson Comprehensive Cancer Center and The University of Texas MD Anderson Cancer Center ...

A new topical gel called LUT014 successfully reduced the severity of a painful acne‐like rash that commonly occurs as a side effect of targeted therapy with epidermal growth factor receptor (EGFR) ...

In recent years, cell therapies have developed alongside chemotherapy and immunotherapy to become a new pillar in the treatment of patients with blood and lymph gland cancer. In solid tumors, such as ...

After first finding multiple tumors on her brain in February, the reality show star finally had some positive news to share ...